PET Response-Guided Treatment of Hodgkin's Lymphoma: A Review of the Evidence and Active Clinical Trials
Risk-adaptive therapy for Hodgkin's lymphoma focuses on treatment modifications based on assessment of response. [18F]Fluoro-deoxyglucose positron emission tomography (PET) performed during or after completion of chemotherapy is a strong prognostic factor for eventual treatment outcome. Concept...
Saved in:
| Main Authors: | Paul Aridgides, Jeffrey Bogart, Anna Shapiro, Ajeet Gajra |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Advances in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2011/309237 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats
by: M. André, et al.
Published: (2011-01-01) -
Brown adipose tissue activity on PET/CT and the course of Hodgkin lymphoma
by: Taner Tan, et al.
Published: (2025-02-01) -
Pathobiology of Hodgkin Lymphoma
by: Pier Paolo Piccaluga, et al.
Published: (2011-01-01) -
FDG PET/CT in Detection of Metastatic Involvement of Heart and Treatment Monitoring in Non-Hodgkin′s Lymphoma
by: Kanhaiyalal Agrawal, et al.
Published: (2012-01-01) -
ADULT NON-HODGKIN'S LYMPHOMA (CLINICAL CASE)
by: Михаил Дмитриевич Неверов, et al.
Published: (2023-06-01)